Australian Pharmaceutical Industries Selects JDA Software to Drive Profitability and Support its Growth and Expansion Objectives.

Leading Health and Beauty Retailer Expects Increased Sales and Reduced Stock Loss with JDA Software's Merchandise Management System 

SYDNEY, Australia & SCOTTSDALE, Ariz. -- JDA([R]) Software Group, Inc. (Nasdaq: JDAS) today announced that Australian Pharmaceutical Industries (API), one of Australia's leading health and beauty companies, has implemented JDA's Merchandise Management System-I (MMS([R])) to optimize its core merchandising system and support its strategic expansion plan. Australian Pharmaceutical operates more than 290 retail stores and pharmacies under the well-known brands Priceline and Priceline Pharmacy.

JDA Software was selected for its superior functionality to replace the retailer's in-house merchandise system, which had limitations within its allocation, store grades, ranging and replenishment functionality. Australian Pharmaceutical needed a new solution that would support its strategic business objectives for opening additional stores and supporting more franchise pharmacies, which was not possible with the old system.

"Our original system did not support our current business and could not be enhanced. JDA's Merchandise Management System provides the core building block of what we need to manage our business. It will also allow us to further implement enhancements to drive profitability, something that the in-house system could not provide," said Simon Kilner, IT manager at Australian Pharmaceutical.

Australian Pharmaceutical implemented Merchandise Management as its primary system and is integrating it with existing best-of-breed solutions that support other parts of the business. Implementation was achieved in 15 months from assembling the project team to go-live. Australian Pharmaceutical expects to realize a sales increase brought about by better availability of products for the consumers, along with improved inventory efficiencies due to the new JDA Software solution.

JDA Software and Australian Pharmaceutical conducted a series of Business Process Analysis sessions to discover how business processes would be addressed by the software. Kilner explained, "The process showed a good match between the system and the business requirement and identified a potential modification list. Key documents like systems reference guides and user reference guides were produced while extensive training and change management took place to ensure success for users."

"We are interested in implementing more JDA products, now that the core merchandise systems have been implemented. We are considering incorporating JDA's solutions for merchandise planning, analysis and trade event management," added Kilner.

"JDA's Merchandise Management solution enables companies to respond quickly to changes in the competitive environment and to achieve operational efficiencies, which will allow the company to profitably grow and expand. We are proud to support Australian Pharmaceutical Industries' business objectives and provide valuable solutions that meet and exceed the needs and expectations of the industry," said Rod Talbot, JDA Software regional vice president, Asia Pacific.

About JDA Software Group, Inc.

JDA([R]) Software Group, Inc. (NASDAQ: JDAS) is focused on helping companies realize real supply chain and revenue management results - fast. JDA Software delivers integrated merchandising as well as supply chain and revenue management planning, execution, and optimization solutions for the consumer-driven supply chain and services industries. Through its industry leading solutions, leading manufacturers, distributors, retailers and services companies around the world are growing their businesses with greater predictability and more profitably. For more information on JDA Software, visit www.jda.com or contact us at [e-mail] or call +1.800.479.7382.

This press release contains forward-looking statements that are made in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally accompanied by words such as "will," and "expect" and other words with forward-looking connotations. In this press release, such forward-looking statements include, without limitation, Mr. Kilner's comments that API is considering licensing additional JDA products, and Mr. Talbot's remarks concerning the anticipated benefits of using our software. The occurrence of future events may involve a number of risks and uncertainties, including, but not limited to: (a) that API may not elect to license additional JDA products; and (b) other risks detailed from time to time in the "Risk Factors" section of our filings with the Securities and Exchange Commission. Additional information relating to the uncertainty affecting our business is contained in our filings with the SEC. As a result of these and other risks, actual results may differ materially from those predicted. JDA is not under any obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

"JDA" and "MMS" are registered trademarks of JDA Software Group. Any trade, product or service name referenced in this document using the name "JDA" is a trademark and/or property of JDA Software Group. All other trade, product, or service names referenced in this release may be trademarks or registered trademarks of their respective holders.